Deliver Your News to the World

Researchers use novel methods to identify how cigarette smoke affects smokers


Scientists say their study aims to understand exactly which toxic chemicals are produced within the body from smoking.

Orlando, Fla. − Smoke from cigarettes can affect nearly every organ in the body by promoting cell damage and causing inflammation, but no one has understood which smoker is or is not susceptible to disease development.

At the American Association for Cancer Research (AACR) 102nd Annual Meeting 2011, however, researchers from Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center, demonstrate how cigarette smoke produces different “metabolites” or active biological compounds, in individual smokers, compared to non-smokers.

In their pilot study, they analyzed hundreds of metabolites found in the blood and urine of nine smokers and 10 non-smokers. The researchers narrowed their focus to the top 50 metabolites in smokers and non-smokers, which differed by group. In the smokers group, the levels of nicotine-related metabolites varied. In addition, overall metabolomic profiles varied among male and female. The researchers validated the reproducibility of the methodology to ensure the experiments were giving low variability.

“This gives us an idea of how people produce metabolites differently when smoking cigarettes, which is based on their particular genetic profile and other biological and environmental factors,” says the study’s lead investigator, Ping-Ching Hsu, a doctoral student who works in the laboratory of oncology researcher Peter Shields, M.D., who specializes in tobacco carcinogenesis, and occasionally serves as an expert witness against cigarette manufacturers in tobacco related litigation. Shields is the senior author.

This study is designed to identify the “metabolome” of individual smokers, which can provide clues as to both the specific effect that cigarette smoking has on human biology, as well as how individuals vary in their internal response to the smoke.

The ultimate goal of this study, which is part of extensive research project, is to find biomarkers in smokers that predict for development of disease in smokers, Hsu says. It can also help in the development of blood tests that will allow researchers to assess the harmfulness of one tobacco product compared to another.

A metabolite is produced when anything taken into the body – such as food, tobacco smoke, alcohol, or medicine – is metabolized, or broken down into chemicals that produce a biological function via metabolic pathways. The global metabolome is the network of metabolic reactions, and metabolomics is analysis of the metabolome at any given time.

Comparatively, cigarette manufacturers have only been required to use machines that “smoked” cigarettes to derive the chemical content of potential carcinogens. “Metabolomics provides a broad picture of what is happening in the body of smokers,” Hsu says.

This is the second study Hsu has presented at an AACR conference. In November, she reported the findings of a study that examined the blood “metabolomics” profile of light versus heavy smokers, and found that smoking behavior could alter several biological pathways.


The study was funded by American Lung Association. The authors declare no conflicts of interest.

About Georgetown Lombardi Comprehensive Cancer Center

The Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Lombardi is one of only 41 comprehensive cancer centers in the nation, as designated by the National Cancer Institute, and the only one in the Washington, DC, area. For more information, go to

About Georgetown University Medical Center

Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC’s mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or “care of the whole person.” The Medical Center includes the School of Medicine and the School of Nursing and Health Studies, both nationally ranked, the world-renowned Lombardi Comprehensive Cancer Center and the Biomedical Graduate Research Organization (BGRO). In fiscal year 2009-2010, GUMC accounted for 79 percent of Georgetown University’s extramural research funding.


This news content was configured by WebWire editorial staff. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.